Looking at Dr Henry Querfurth's credentials, he is a leader in the field with 39 years experience and distinguishments in Alzheimers research.
It feels like we have been standing in front of a locked door regarding neurodegenerative diseases and now we are close to finding the key to open the lock. Let's hope that our molecule monepantel is the key to open that door.
The significance of the MND trial cannot be understated. A degree of success will transform current treatments for MND and have a cascade effect to examine treatments of many other neurodegenerative diseases.
Great research as usual kpax. Exciting times ahead!
PAA Price at posting:
8.6¢ Sentiment: Buy Disclosure: Held
(20min delay)